Target & Activity
| Target | Activity | Value |
|---|---|---|
| NAMPT | 25 nM | |
| NAMPT | Kd | 120 nM |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A2780 | IC50 | 0.001 μM | Inhibition of NAMPT in human A2780 cells assessed as decrease in cell viability after 72 hrs by SRB assay | [PMID: 27541271] |
| A2780 | IC50 | 0.005 μM | Cytotoxicity against human A2780 cells after 72 hrs by SRB assay | [PMID: 23617784] |
| A2780 | IC50 | 0.005 μM | Antiproliferative activity against human A2780 cells after 72 hrs by sulforhodamine B assay | [PMID: 24405419] |
| A2780 | IC50 | 0.005 μM | Antiproliferative activity against human A2780 cells assessed as growth inhibition after 72 hrs by SRB-based microplate reader analysis | [PMID: 23859118] |
| A2780 | IC50 | 0.56 nM | Cytotoxicity against human A2780 cells assessed as growth inhibition after 72 hrs by WST-1 assay | [PMID: 24164086] |
| DLD-1 | IC50 | 2315 nM | Cytotoxicity against human DLD1 cells after 24 hrs by SRB assay | [PMID: 25147148] |
| DLD-1 | IC50 | 2315 nM | Anticancer activity against human DLD-1 cells assessed as cell growth inhibition incubated for 24 hrs | [PMID: 35694689] |
| HA22T cell line | IC50 | 2067 nM | Cytotoxicity against human HA22T cells after 24 hrs by SRB assay | [PMID: 25147148] |
| HA22T cell line | IC50 | 2067 nM | Anticancer activity against human HA22T cells assessed as cell growth inhibition incubated for 24 hrs | [PMID: 35694689] |
| HepG2 | IC50 | 1245 nM | Cytotoxicity against human HepG2 cells after 24 hrs by SRB assay | [PMID: 25147148] |
| HepG2 | IC50 | 1245 nM | Anticancer activity against human HepG2 cells assessed as cell growth inhibition incubated for 24 hrs | [PMID: 35694689] |
| HepG2 | IC50 | 18.3 nM | Inhibition of NAMPT in human HepG2 cells using [14C]-nicotinamide/PRPP as substrate assessed as formation of [14C]-nicotinamide mononucleotide after 1 hr by liquid scintillation counting analysis | [PMID: 24164086] |
| HONE1 cell line | IC50 | 15 nM | Cytotoxicity against human HONE1 cells after 24 hrs by SRB assay | [PMID: 25147148] |
| HONE1 cell line | IC50 | 15 nM | Anticancer activity against human HONE1 cell line assessed as cell growth inhibition incubated for 24 hrs | [PMID: 35694689] |
| MCF7 | IC50 | 1.6 nM | Cytotoxicity against human MCF-7 cells assessed as growth inhibition after 72 hrs by WST-1 assay | [PMID: 24164086] |
| MCF7 | IC50 | 18 nM | Anticancer activity against human MCF7 cells assessed as cell growth inhibition incubated for 24 hrs | [PMID: 35694689] |
| NUGC | IC50 | 25 nM | Cytotoxicity against human NUGC cells after 24 hrs by SRB assay | [PMID: 25147148] |
| NUGC | IC50 | 25 nM | Anticancer activity against human NUGC cells assessed as cell growth inhibition incubated for 24 hrs | [PMID: 35694689] |
| PC-3 | IC50 | 4.4 nM | Antiproliferative activity against human PC3 cells assessed as reduction in cell viability incubated for 5 days by Cell-titer Glo reagent based assay | [PMID: 28610984] |
19 records · Scroll to view more